SCHEMBL25433611

SCHEMBL25433611

CS(=O)(=O)Nc1cccc(NC(=O)c2ccc(-n3cccn3)cc2)c1

nearest known ligand 0.58

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
DHX9 Q08211 1/20 0.58
HPGD P15428 2/20 0.55
TP53 P04637 1/20 0.52
NAMPT P43490 1/20 0.51
SIRT2 Q8IXJ6 1/20 0.51
SIRT1 Q96EB6 1/20 0.51
SIRT3 Q9NTG7 1/20 0.51
MAPT P10636 5/20 0.50
MEN1 O00255 4/20 0.50
KMT2A Q03164 4/20 0.50
KDM4E B2RXH2 2/20 0.50
TDP1 Q9NUW8 1/20 0.50
PKM P14618 1/20 0.50
ALDH1A1 P00352 2/20 0.48
LMNA P02545 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.47
TNIK Q9UKE5 1/20 0.46
RXFP1 Q9HBX9 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31610057 1.00 DHX9 (0.58) DHX9HPGDTP53NAMPTSIRT2
SCHEMBL31610063 0.90 DHX9 (0.57) DHX9HPGDNAMPTMAPTMEN1
SCHEMBL25431434 0.90 DHX9 (0.57) DHX9HPGDNAMPTMAPTMEN1
SCHEMBL26043484 0.82 HPGD (0.61) DHX9HPGDNAMPTSIRT2SIRT1
SCHEMBL31610112 0.81 DHX9 (0.52) DHX9HPGDMAPTMEN1KMT2A
SCHEMBL4250109 0.81 KDM4E (0.73) HPGDTP53SIRT2SIRT1SIRT3
SCHEMBL4253031 0.80 RAB9A (0.62) HPGDTP53NAMPTSIRT2SIRT1
SCHEMBL25351911 0.80 KAT6A (0.51) DHX9HPGDMAPTMEN1KMT2A
SCHEMBL25353685 0.80 KAT6A (0.51) DHX9HPGDTP53MAPTMEN1
SCHEMBL30535596 0.80 KAT6A (0.51) DHX9HPGDMAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4479380-A1 INHIBITORS OF RNA HELICASE DHX9 AND USES THEREOF Accent Therapeutics, Inc. (US) 2024-12-25 EP claimed
WO-2023158795-A1 INHIBITORS OF RNA HELICASE DHX9 AND USES THEREOF ACCENT THERAPEUTICS, INC. (US) 2023-08-24 WO claimed
EP-4479380-A1 INHIBITORS OF RNA HELICASE DHX9 AND USES THEREOF Accent Therapeutics, Inc. (US) 2024-12-25 EP disclosed
WO-2023158795-A1 INHIBITORS OF RNA HELICASE DHX9 AND USES THEREOF ACCENT THERAPEUTICS, INC. (US) 2023-08-24 WO disclosed
WO-2023158795-A1 INHIBITORS OF RNA HELICASE DHX9 AND USES THEREOF ACCENT THERAPEUTICS, INC. (US) 2023-08-24 WO disclosed